| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,700,000 |
| Market
Cap: |
186.58(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.93 - $7.455 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 20.1 |
| Insider 3/6 Months : 20.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Verrica Pharmaceuticals is a dermatology therapeutics company focused on the development and commercialization of treatments for people living with skin diseases. Co.'s primary product candidate, VP-102, is a proprietary drug-device combination of its topical solution of cantharidin, a naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. Co. is initially developing VP-102 for the treatment of molluscum contagiosum, a highly contagious and primarily pediatric viral skin disease, external genital warts and common warts.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
2,060,199 |
2,260,199 |
8,757,101 |
| Total Buy Value |
$0 |
$12,503,039 |
$13,507,039 |
$27,160,283 |
| Total People Bought |
0 |
1 |
2 |
6 |
| Total Buy Transactions |
0 |
9 |
10 |
18 |
| Total Shares Sold |
0 |
137,181 |
288,608 |
288,608 |
| Total Sell Value |
$0 |
$403,821 |
$1,135,213 |
$1,135,213 |
| Total People Sold |
0 |
5 |
5 |
5 |
| Total Sell Transactions |
0 |
10 |
14 |
14 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hayes Christopher G. |
Chief Legal Officer |
• – – |
2021-06-04 |
4 |
B |
$9.79 |
$24,475 |
D/D |
2,500 |
2,500 |
2.74 |
27% |
|
| Manning Paul B |
Director |
– • • |
2021-03-25 |
4 |
B |
$14.75 |
$10,912,493 |
I/I |
739,830 |
739,830 |
2.25 |
-22% |
|
| Manning Paul B |
Director |
– • • |
2020-08-20 |
4 |
B |
$9.09 |
$181,800 |
D/D |
20,000 |
8,099,394 |
3.92 |
30% |
|
| Manning Paul B |
Director |
– • • |
2020-08-18 |
4 |
B |
$8.55 |
$85,500 |
I/I |
10,000 |
1,481,719 |
2.25 |
40% |
|
| Manning Paul B |
Director |
– • • |
2020-08-17 |
4 |
B |
$6.92 |
$41,520 |
I/I |
6,000 |
1,471,719 |
2.25 |
60% |
|
| Stalfort Sean |
Director |
– • – |
2020-08-14 |
4 |
B |
$6.38 |
$100,166 |
D/D |
15,700 |
462,110 |
2.39 |
78% |
|
| Manning Paul B |
Director |
– • • |
2020-08-14 |
4 |
B |
$6.51 |
$325,500 |
I/I |
50,000 |
1,465,719 |
2.25 |
78% |
|
| White Ted |
President and CEO |
• • – |
2020-08-13 |
4 |
B |
$6.28 |
$66,951 |
D/D |
10,661 |
17,966 |
2.81 |
91% |
|
| Davis A Brian |
Chief Financial Officer |
• – – |
2020-08-13 |
4 |
B |
$6.24 |
$49,296 |
D/D |
7,900 |
7,900 |
2.74 |
91% |
|
| Stalfort Sean |
Director |
– • – |
2020-08-13 |
4 |
B |
$6.45 |
$100,298 |
D/D |
15,550 |
446,410 |
2.39 |
91% |
|
| Manning Paul B |
Director |
– • • |
2020-08-13 |
4 |
B |
$6.41 |
$695,485 |
I/I |
108,500 |
1,415,719 |
2.25 |
91% |
|
| Nguyen Diem |
Director |
– • – |
2020-06-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100 |
|
-34% |
|
| Manning Paul B |
Director |
– • • |
2019-10-10 |
4 |
B |
$15.05 |
$103,845 |
D/D |
6,900 |
8,079,394 |
3.92 |
- |
|
| Manning Paul B |
Director |
– • • |
2019-10-09 |
4 |
B |
$14.06 |
$123,419 |
D/D |
8,778 |
8,072,494 |
3.92 |
- |
|
| Manning Paul B |
Director |
– • • |
2019-10-08 |
4 |
B |
$14.02 |
$73,016 |
D/D |
5,208 |
8,063,716 |
3.92 |
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-09-09 |
4 |
AS |
$10.82 |
$68,166 |
D/D |
(6,300) |
2,556,179 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-09-06 |
4 |
AS |
$10.38 |
$110,268 |
D/D |
(9,914) |
2,562,479 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-09-05 |
4 |
AS |
$10.29 |
$31,899 |
D/D |
(3,100) |
2,572,393 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-29 |
4 |
AS |
$10.14 |
$22,186 |
D/D |
(2,188) |
2,575,493 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-27 |
4 |
AS |
$10.23 |
$5,115 |
D/D |
(500) |
2,577,681 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-09 |
4 |
AS |
$10.21 |
$28,312 |
D/D |
(2,773) |
2,578,181 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-08 |
4 |
AS |
$10.76 |
$33,550 |
D/D |
(3,118) |
2,580,954 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-07 |
4 |
AS |
$10.28 |
$4,338 |
D/D |
(422) |
2,584,072 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-06 |
4 |
AS |
$10.28 |
$26,749 |
D/D |
(2,602) |
2,584,494 |
|
- |
|
| Davidson Matt |
10% Owner |
– – • |
2019-08-05 |
4 |
AS |
$10.65 |
$17,881 |
D/D |
(1,679) |
2,587,096 |
|
- |
|
246 Records found
|
|
Page 3 of 10 |
|
|
0.50 (7.4%) 
